Posts with tag: instructions
Pfizer beats Q4 and full-year 2024 earnings estimates, driven by strong performance in key segments. Despite headwinds such as patent expirations and Medicare price negotiations, the company remains focused on pipeline development and cost-cutting initiatives.
Published on: February 04, 2025, 04:02 PM UTC